Clinical Trial Update: Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates that TH9619 is being studied in a Phase 1/2 trial for advanced solid tumors, with recruitment ongoing and including colorec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of Head and Neck

Drugs mentioned

• TH9619

Snippet

Sponsor: One-carbon Therapeutics AB | Conditions: Solid Tumor, Colorectal Cancer (CRC) | Phase 1, Phase 2 | Status: RECRUITING